Hello and welcome. It is my great pleasure to introduce to you the third edition of the European Medical Journal for 2018: EMJ 3.3. As always, our flagship journal melds articles from a variety of therapeutic disciplines together to create a truly unique and rewarding reading experience. This edition details wonderful research from many areas of interest, with rheumatology and haematology particularly well represented in the following pages.
Genome Editing as a Vehicle to Drive Successful Chimeric Antigen Receptor T Cell Therapies to the Clinic